Lifelong monitoring (â‰¥4x/day) of blood glucose concentrations is indicated to achieve the goals of therapy.

Children with PNDM, particularly those with a pathogenic variant in KCNJ11 or ABCC8, should undergo periodic developmental evaluations.

Yearly screening for chronic complications associated with diabetes mellitus should be started after age ten years and should include the following:

Urinalysis for microalbuminuria

Ophthalmologic examination to screen for retinopathy
